Fig. 1
From: AZD2014, a dual mTOR inhibitor, attenuates cardiac hypertrophy in vitro and in vivo
Time course of changes in myocardial mTOR signaling in phenylephrine (PE)-induced cardiac hypertrophy due to AZD2014 treatment. a Effects of AZD2014 on Akt, mTOR and S6 phosphorylation from PE-induced cardiac hypertrophy evaluated by western blot. b Quantitative densitometry of phosphorylated/total protein expression from western blots by ImageJ. #, p > 0.05; *, p < 0.05. n = 3